Perrigo Co. Plc (PRGO)

49.67
NYSE : Health Technology
Prev Close 49.90
Day Low/High 49.30 / 50.14
52 Wk Low/High 36.28 / 80.66
Avg Volume 1.31M
Exchange NYSE
Shares Outstanding 135.99M
Market Cap 6.79B
EPS 0.90
P/E Ratio 58.71
Div & Yield 0.84 (1.53%)
Stocks Tank as Trump, North Korea Exchange Barbs

Stocks Tank as Trump, North Korea Exchange Barbs

North Korea strikes Wall Street again.

Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions

Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions

The healthcare firm has agreed to sell its active pharmaceutical ingredients business and its Russia consumer healthcare international unit.

S&P 500 at Session Lows, Dow Under 22,000 on North Korea Threat

S&P 500 at Session Lows, Dow Under 22,000 on North Korea Threat

Stocks are lower.

Midday Report: Macy's Sinks Kohl's; Wall Street Down for Day Three

Midday Report: Macy's Sinks Kohl's; Wall Street Down for Day Three

Stocks fall for their third day in a row.

Dow Tumbles as North Korea Tensions Simmer

Dow Tumbles as North Korea Tensions Simmer

Stocks are lower.

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Perrigo leading the charge.

Israel's Stock Market Is Having a Disastrous Week

Israel's Stock Market Is Having a Disastrous Week

Teva's not the only one struggling to stay afloat in Israel.

How You Can Beat the Still Astronomical Prices for Prescription Drugs

How You Can Beat the Still Astronomical Prices for Prescription Drugs

The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.

Activists Forced CEOs to Leave These Huge Companies This Year

Activists Forced CEOs to Leave These Huge Companies This Year

The top executives at these seven companies all left after pressure from activist investors in 2017.

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.

Closing Bell: U.S. Stocks Fall Over Session, Rise for May; Perrigo Bests S&P 500

Closing Bell: U.S. Stocks Fall Over Session, Rise for May; Perrigo Bests S&P 500

Stocks significantly pared losses by the end of the session, though still ended slightly lower.

Perrigo Stock Jumps on 1Q Beat

Perrigo Stock Jumps on 1Q Beat

The quarter's success, Canaccord Genuity analyst Dewey Steadman argued, means Perrigo has removed an overhang.

Market Recon: Watch Core Inflation for a Hint of What the Fed Will Do

Market Recon: Watch Core Inflation for a Hint of What the Fed Will Do

Core CPI has slowed on a year-over-year basis now for three consecutive months.

Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs

Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs

The latest earnings from two of the largest generic drug makers show how important it is for generic firms to have their own stable of higher-margin branded products.

Greenlight Capital Quadrupled General Motors Stake in Activist Push

Greenlight Capital Quadrupled General Motors Stake in Activist Push

David Einhorn is going all-in on General Motors.

Group Stink; Good, the Bad and the Ugly: Doug Kass' Views

Group Stink; Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on Facebook, Allergan and Apple.

S&P 500 Lower After Fed Leaves Rates Unchanged, Dow Turns Higher

S&P 500 Lower After Fed Leaves Rates Unchanged, Dow Turns Higher

Stocks hold mostly lower on Wednesday after the Federal Reserve's policy-making group decides to leave its federal funds rate unchanged.

Generics Drop Across Board as DOJ Inquiry Expands

Generics Drop Across Board as DOJ Inquiry Expands

The addition of Perrigo to the list of generics makers under investigation is more bad news for a sector already under pressure from low prices.

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Perrigo Company Plc

Goldberg Law PC announces that it is investigating Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) concerning possible violations of federal securities laws.

PERRIGO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Perrigo Co. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Perrigo Co.

Perrigo Shares Fall After Disclosing DOJ Investigation

Perrigo Shares Fall After Disclosing DOJ Investigation

The search involves a Department of Justice Antitrust Division investigation in relation to drug pricing in the pharmaceutical industry

Stock Losses Deepen as Oil Tumbles, Apple Falls and Wall Street Awaits the Fed

Stock Losses Deepen as Oil Tumbles, Apple Falls and Wall Street Awaits the Fed

Stock losses deepen on Wednesday morning after crude oil turns negative and a decision from the Federal Reserve looms.

Perrigo Stock Sliding on DOJ Search

Perrigo Stock Sliding on DOJ Search

The investigation is in relation to drug pricing in the pharmaceutical industry.

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share.

Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views

Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on whether Judgment Day is here for the financials and discusses General Electric, Apple and Caterpillar.

The New #102 Most Shorted S&P 500 Component: Perrigo Company

The most recent short interest data has been released for the 03/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Perrigo Company Becomes #209 Most Shorted S&P 500 Component, Replacing Flowserve

The most recent short interest data has been released for the 03/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

The Street took a look at the top 15 activist hedge funds and their director-election records over the past six years

TheStreet Quant Rating: D+ (Sell)